Association of Northern California Oncologists

http://www.anco.org/

 

2019 ANCO's ASCO Highlights in Metastatic Prostate Cancer: New Data on Enzalutamide in mHSPC, Apalutamide+ADT in mCSPC, and Concurrent 2 Hormonal Agents in mCRPC

224 views
September 6, 2019
0 Comments
Login to view comments. Click here to Login